YIH
ACET icon

Y-Intercept (HK)’s Adicet Bio ACET Stock Holding History

Y-Intercept (HK)’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,957
Closed -$231K – 1242
2024
Q2 		$231K Buy
+11,957
New +$320K 0.01% 1121
2023
Q3 		– Sell
-1,681
Closed -$65.3K – 1005
2023
Q2 		$65.3K Buy
+1,681
New +$148K 0.01% 1176

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Y-Intercept (HK)'s ACET Position: Q3 2024 in Review

Y-Intercept (HK) sold out of Adicet Bio (ACET) in Q3 2024, closing a stake of 11,957 shares — an estimated $231K sold.

Y-Intercept (HK) first reported a position in ACET in Q2 2023 and held it in 2 quarters. The position peaked at $231K in Q2 2024. 64 funds tracked by Wall St. Rank hold ACET as of Q3 2024.

  • Y-Intercept (HK) reported no remaining Adicet Bio position as of Q3 2024 after selling out during the quarter.
  • Y-Intercept (HK) sold 11,957 Adicet Bio shares in Q3 2024, an estimated $231K.
  • Y-Intercept (HK) first reported a position in Adicet Bio in Q2 2023 and held it in 2 quarters.
  • Y-Intercept (HK)'s Adicet Bio position peaked at $231K in Q2 2024.
  • 64 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2024.

Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.